Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Multicentre Non-interventional Study to Assess CRT Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

NCT05887011 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05887011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05887011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Multicentre Non-interventional Study to Assess CRT Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
March 31, 2023
Completion date
June 30, 2026
Enrollment
2,000 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable /inoperable locally advanced (stage ii-iii) nsclc and locally advanced ls-sclc (stage i-iii)